BiotechTube

AUTO CAR T cell therapy

Phase 2Recruiting
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy

Conditions

Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy, Multiple Myeloma, DLBCL, ALL, Adult and Pediatric, T Cell Lymphoma

Trial Timeline

Aug 2, 2018 → Dec 1, 2043

NCT ID
NCT03628612

About AUTO CAR T cell therapy

AUTO CAR T cell therapy is a phase 2 stage product being developed by Autolus Therapeutics for Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy. The current trial status is recruiting. This product is registered under clinical trial identifier NCT03628612. Target conditions include Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy, Multiple Myeloma, DLBCL.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT03628612Phase 2Recruiting

Competing Products

20 competing products in Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy

See all competitors
ProductCompanyStageHype Score
R744 + R744Chugai PharmaceuticalPhase 3
77
R744 + R744 + rHuEPO + rHuEPO + R744 placebo + rHuEPO placeboChugai PharmaceuticalPhase 3
77
R744 + Epoetin betaChugai PharmaceuticalPhase 3
77
R744 + R744Chugai PharmaceuticalPhase 3
77
R744 + R744Chugai PharmaceuticalPhase 3
77
R744Chugai PharmaceuticalPhase 3
77
PLX3397 + TemozolomideDaiichi SankyoPhase 1/2
41
FK949EAstellas PharmaPhase 1
33
roxadustatAstellas PharmaPhase 3
77
roxadustatAstellas PharmaPhase 3
77
Roxadustat + Darbepoetin alfaAstellas PharmaPhase 3
77
ASP8825Astellas PharmaPhase 1
33
ASP015KAstellas PharmaPhase 1
33
ASP7991Astellas PharmaPhase 1
33
Roxadustat + Epoetin AlfaAstellas PharmaPhase 3
77
ATG-FAstellas PharmaApproved
85
CelecoxibAstellas PharmaPre-clinical
23
roxadustat + Darbepoetin alfaAstellas PharmaPhase 3
77
roxadustatAstellas PharmaPhase 3
77
FK949EAstellas PharmaPhase 1
33

Other Products from Autolus Therapeutics

Obecabtagene autoleucelPhase 2
44
Obecabtagene autoleucelPhase 2
44
Obecabtagene AutoleucelPhase 2
44
AUTO3Phase 1/2
33
AUTO4Phase 1/2
33